Brussee, Janneke M <br/><br/>
First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.  [electronic resource] 

 -  CPT: pharmacometrics & systems pharmacology  06 2018 
 - 374-383 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2163-8306 
<br/><br/><label>Standard No.: </label>10.1002/psp4.12295  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Administration, Oral<br/>Biological Availability<br/>Cytochrome P-450 CYP3A--metabolism<br/>Humans<br/>Infant, Premature<br/>Intestinal Mucosa--chemistry<br/>Liver--chemistry<br/>Midazolam--administration & dosage<br/>Models, Biological<br/>Random Allocation